Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies

Published:2021-06-28 Issue:3 Volume:51 Page:890-897
ISSN:1303-6165
Container-title:TURKISH JOURNAL OF MEDICAL SCIENCES
language:
Short-container-title:Turk J Med Sci

Author:

SARFRAZ Azza^ORCID,SARFRAZ Zouina^ORCID,SARFRAZ Muzna^ORCID,AFTAB Hinna^ORCID,PERVAIZ Zainab^ORCID

Publisher

The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM)

Subject

General Medicine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2024-04-19

2. The role of clinical and immunological parameters in predicting the effectiveness of additional immunotropic therapy in oxygen-dependent patients with COVID-19 coronavirus disease;Pathologia;2023-12-22

3. Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-12-02

4. Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis;European Journal of Inflammation;2023-08-25

5. Comparing oxygen demand in critical covid-19 patients using single versus double doses of tocilizumab;Saudi Medical Journal;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP